News
-
-
-
REGULATED PRESS RELEASE
bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
bioMérieux launches SPINCHIP® hs-cTnl, a rapid diagnostic solution for high-sensitivity cardiac troponin I measurement, enabling faster triage of adult patients with suspected acute myocardial infarction -
-
REGULATED PRESS RELEASE
bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
bioMérieux achieves IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, including MERS-CoV. The certification reinforces the company's commitment to providing comprehensive diagnostic solutions for infectious diseases -
-
-
REGULATED PRESS RELEASE
bioMérieux – First-Half 2026 Results
-
-